Coppola Lab - GIFT Variant Database
APP (amyloid beta precursor protein)
LOVD v.3.0 Build 21 [
Current LOVD status
]
Register as submitter
|
Log in
Curator:
Ariane Ayer
View all genes
View APP gene homepage
View graphs about the APP gene database
View all transcripts
View all transcripts of gene APP
View all genomic variants
View all variants affecting transcripts
View unique variants in gene APP
View all variants in gene APP
Full data view for gene APP
View all individuals
View all individuals with variants in gene APP
View all diseases
View all diseases associated with gene APP
View all screenings
View all screenings for gene APP
Submit new data
Full data view for gene APP
The variants shown are described using the NM_000484.3 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the protein's function, in the format 'R/C' where R is the value reported by the source and C is the value concluded by the curator; '+' indicating the variant affects function, '+?' probably affects function, '+*' affects function, not associated with individual's disease phenotype, '#' affects function, not associated with any known disease phenotype, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect not classified.
Exon
: Number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = exons 3 to 7, 8i_9 = border intron 8/exon 9.
DNA change (cDNA)
: Description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup.
RNA change
: Description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: Description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Allele
: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
DNA change (genomic) (hg19)
: Description of variant at DNA level, based on the genomic DNA reference sequence (following HGVS recommendations).
g.12345678C>T
g.12345678_12345890del
g.12345678_12345890dup
Frequency in study
: Frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested).
ExAC MAF
: Total allele Frequency in the ExAC database (http://exac.broadinstitute.org/)
gnomAD MAF
: Total allele Frequency in the gnomAD database (http://gnomad.broadinstitute.org/)
Segregation
: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = Unknown
yes = Segregates with phenotype
no = Does not segregate with phenotype
# Affected Unrelated
: Number of affected unrelated individuals
De novo
: Indicates whether the variant was found de novo (yes) or not (no) or if it is unknown
All options:
Yes
No
?
Variant remarks
: Remarks regarding the variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference
: Reference to publication describing the variant, including links to OMIM (when available), PubMed or or other source, e.g. "den Dunnen ASHG2003 P2346".
Suggested ACMG
: Variant classification following the standards and guideline recommendations of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (Richards et al. Genet Med. 2015)
All options:
Pathogenic
Likely pathogenic
Uncertain significance
Likely benign
Benign
AD&FTD Classification
: Classification on AD&FTD, if applicable
All options:
Pathogenic
Uncertain
Benign
Other Classification
: Classification by others: authors, AD&FTD, ClinVar, etc as applicable
DB-ID
: Database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro.
Template
: Template(s) used to detect the sequence variant; DNA = genomic DNA, RNA = RNA (cDNA).
All options:
DNA
RNA = RNA (cDNA)
Protein
? = unknown
Technique
: Technique(s) used to identify the sequence variant.
All options:
? = Unknown
arrayCGH = array for Comparative Genomic Hybridisation
arraySEQ = array for resequencing
arraySNP = array for SNP typing
arrayCNV = array for Copy Number Variation (SNP and CNV probes)
BESS = Base Excision Sequence Scanning
CMC = Chemical Mismatch Cleavage
CSCE = Conformation Sensitive Capillary Electrophoresis
DGGE = Denaturing-Gradient Gel-Electrophoresis
DHPLC = Denaturing High-Performance Liquid Chromatography
DOVAM = Detection Of Virtually All Mutations (SSCA variant)
ddF = dideoxy Fingerprinting
DSCA = Double-Strand DNA Conformation Analysis
EMC = Enzymatic Mismatch Cleavage
HD = HeteroDuplex analysis
MCA = high-resolution Melting Curve Analysis (hrMCA)
IHC = Immuno-Histo-Chemistry
MAPH = Multiplex Amplifiable Probe Hybridisation
MLPA = Multiplex Ligation-dependent Probe Amplification
SEQ-NG = Next-Generation Sequencing
SEQ-NG-H = Next-Generation Sequencing - Helicos
SEQ-NG-I = Next-Generation Sequencing - Illumina/Solexa
SEQ-NG-R = Next-Generation Sequencing - Roche/454
SEQ-NG-S = Next-Generation Sequencing - SOLiD
Northern = Northern blotting
PCR = Polymerase Chain Reaction
PCRdig = PCR + restriction enzyme digestion
PCRlr = PCR, long-range
PCRm = PCR, multiplex
PCRq = PCR, quantitative
PAGE = Poly-Acrylamide Gel-Electrophoresis
PTT = Protein Truncation Test
PFGE = Pulsed-Field Gel-Electrophoresis (+Southern)
RT-PCR = Reverse Transcription and PCR
SEQ = SEQuencing
SBE = Single Base Extension
SSCA = Single-Strand DNA Conformation polymorphism Analysis (SSCP)
SSCAf = SSCA, fluorescent (SSCP)
Southern = Southern blotting
TaqMan = TaqMan assay
Western = Western Blotting
Reference
: Reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, including link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346". References in the "Country:City" format indicate that the variant was submitted directly to this database by the laboratory indicated.
Remarks
: Remarks about the individual.
52 entries on 1 page. Showing entries 1 - 52.
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
Effect
Exon
DNA change (cDNA)
RNA change
Protein
Allele
DNA change (genomic) (hg19)
Frequency in study
ExAC MAF
gnomAD MAF
Segregation
# Affected Unrelated
De novo
Variant remarks
Reference
Suggested ACMG
AD&FTD Classification
Other Classification
DB-ID
Template
Technique
Disease
Reference
Remarks
Panel size
Owner
./.
-
c.()
r.(?)
dupAPP[ALZ254]
Unknown
g.12843139_41952861dup
1/56 ADEOAD families
-
-
?
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT187]
Unknown
g.13343139_41452861dup
1/56 ADEOAD families
-
-
?
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000012
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT144]
Unknown
g.17843139_36952861dup
1/56 ADEOAD families
-
-
yes
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000012
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT145]
Unknown
g.21543139_33252861dup
1/56 ADEOAD families
-
-
?
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT054]
Unknown
g.25943139_28852861dup
1/56 ADEOAD families
-
-
?
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT279]
Unknown
g.26363139_28432861dup
1/56 ADEOAD families
-
-
?
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT298]
Unknown
g.26713139_28082861dup
1/56 ADEOAD families
-
-
?
1
?
-
Wallon, 2012
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[3]
Unknown
g.14562516_33200096dup
1/381 AD patients
-
-
?
1
?
associated with seizures, APOE genotype e3/e3
McNaughton, 2012
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[2]
Unknown
g.22355848_28847265dup
1/381 AD patients
-
-
?
1
?
associated with seizures, APOE genotype e3/e4
McNaughton, 2012
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[1]
Unknown
g.22482249_28827690dup
1/381 AD patients
-
-
?
1
?
associated with seizures, APOE genotype e3/e4
McNaughton, 2012
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[4]
Unknown
g.26669326_31626912dup
1/381 AD patients
-
-
?
1
?
APOE genotype e3/e4
McNaughton, 2012
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[5]
Unknown
g.27084999_29852914dup
1/381 AD patients
-
-
?
1
?
associated with seizures, APOE genotype e3/e3
McNaughton, 2012
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[F229]
Unknown
g.19641690_30365224dup
1 ADEOAD family
-
-
?
1
?
associated with CAA
Rovelet-Lecrux, 2006
Pathogenic
Pathogenic
N/A
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[F037]
Unknown
g.25801054_27945581dup
1 ADEOAD family
-
-
?
1
?
associated with CAA
Rovelet-Lecrux, 2006
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[F009]
Unknown
g.25801054_30365224dup
1 ADEOAD family
-
-
?
1
?
associated with CAA
Rovelet-Lecrux, 2006
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[F019]
Unknown
g.25801054_31312282dup
1 ADEOAD family
-
-
?
1
?
associated with CAA
Rovelet-Lecrux, 2006
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[F028]
Unknown
g.26802078_27945581dup
1 ADEOAD family
-
-
?
1
?
associated with CAA
Rovelet-Lecrux, 2006
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[PED3281]
Unknown
g.24778131_29078128dup
1/25 FAD families
-
-
?
1
?
-
Kasuga, 2009
Pathogenic
Pathogenic
Authors: uncertain
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[PED2945]
Unknown
g.27178131_27945581dup
1/25 FAD families
-
-
?
1
?
-
Kasuga, 2009
Pathogenic
Pathogenic
Authors: uncertain
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[VI]
Unknown
g.25062878_28544658dup
1/1536 AD patients
-
-
no
1
No
duplication present in 3 affected individuals + 1 unaffected individual, and not found in another unaffected individual
Hooli, 2012
Likely pathogenic
Pathogenic
Authors: likely pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[BRB]
Unknown
g.27203799_27583320dup
1/1536 AD patients
-
-
no
1
No
duplication present in 2/3 affected siblings, not present in unaffected individuals
Hooli, 2012
Likely pathogenic
Pathogenic
Authors: likely pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[EXT773]
Unknown
g.23561983_31154110dup
1/14 sporadic EOAD trios
-
-
?
1
Yes
De novo duplication, encompasses APP and 15 other genes
Rovelet-Lecrux, 2015
Pathogenic
Pathogenic
Authors: pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP
Unknown
g.26993133_27802861dup
1 ADEOAD family
-
-
?
1
No
Identified in all 3 affected family members tested, all with APOE e3/e3 and diversity of phenotype
Guyant-Marechal, 2008
Pathogenic
Pathogenic
Authors: likely pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[Swedish]
Unknown
g.27028855_28122014dup
1/22 AD patients
-
-
?
1
?
-
Thonberg, 2011
Pathogenic
Pathogenic
Authors: likely pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[Finnish]
Unknown
g.27107700_27838529dup
1 family with dementia/ICH/CAA
-
-
?
1
?
-
Rovelet-Lecrux, 2007
Pathogenic
Pathogenic
Authors: likely pathogenic
APP_000010
-
-
-
-
-
-
-
./.
-
c.()
r.(?)
dupAPP[1104]
Unknown
g.27144340_c27838529dup
1/10 EOAD families
-
-
?
1
?
associated with seizures
Sleegers, 2006
Pathogenic
Pathogenic
Authors: likely pathogenic
APP_000010
-
-
-
-
-
-
-
./.
16
c.[2010G>T;2011A>C]
r.(?)
p.[K670N;M671L]
Unknown
g.27269938G>T;27269939A>C
2 related AD families
-
-
yes
1
?
-
Mullan, 1992
Likely pathogenic
Pathogenic
Authors: likely pathogenic
APP_000002
-
-
-
-
-
-
-
./.
17
c.[2137G>A;2145G>A]
r.(?)
p.(Ala713Thr)
Unknown
g.27264108G>A
1 AD patient
-
-
no
1
No
found in 5 relatives of similar age without disease
Carter, 1992
Uncertain significance
Uncertain
Authors: uncertain
APP_000006
-
-
-
-
-
-
-
./.
16
c.2032G>A
r.(?)
p.(Asp678Asn)
Unknown
g.27269917G>A
-
-
-
-
1
-
-
Wakutani, 2004
;
Wakutani, 2005
Likely pathogenic
Pathogenic
N/A
APP_000024
-
-
-
-
-
-
-
./.
12
c.2044G>A
r.(?)
p.(Glu682Lys)
Unknown
g.27269905G>A
1 EOAD patient
-
-
?
1
?
-
Brouwers, 2008
Uncertain significance
Pathogenic
Authors: uncertain
APP_000001
-
-
-
-
-
-
-
./.
17
c.2075C>G
r.(?)
p.(Ala692Gly)
Unknown
g.27264170C>G
-
-
-
-
2
-
-
Hendricks, 1992
;
Roks, 2000
;
Kumar-Singh, 2002
Likely pathogenic
Pathogenic
N/A
APP_000025
-
-
-
-
-
-
-
./.
17
c.2077G>A
r.(?)
p.(Glu693Lys)
Unknown
g.27264168G>A
1 AD family
-
-
-
-
-
Couldn't find paper
Tagliavini, 1999
Likely pathogenic
Pathogenic
N/A
APP_000003
-
-
-
-
-
-
-
./.
17
c.2077G>C
r.(?)
p.(Glu693Gln)
Unknown
g.27264168G>C
-
-
-
-
4
-
-
Levy, 1990
;
Van Broeckhoven, 1990
;
Fernandez-Madrid, 1991
Likely pathogenic
Pathogenic
N/A
APP_000026
-
-
-
-
-
-
-
./.
17
c.2078A>G
r.(?)
p.(Glu693Gly)
Unknown
g.27264167A>G
-
-
-
-
2
-
-
Kamino, 1992
; Nilsberth, 2000;
Nilsberth, 2001
Likely pathogenic
Pathogenic
N/A
APP_000027
-
-
-
-
-
-
-
./.
17
c.2079_2081delAGA
r.(?)
p.(Glu693del)
Unknown
g.27264164_27264166delAGA
1 AD patient
-
-
-
4
-
-
Tomiyama, 2008
Likely pathogenic
Pathogenic
Authors: likely pathogenic
APP_000004
-
-
-
-
-
-
-
./.
17
c.2080G>A
r.(?)
p.(Asp694Asn)
Unknown
g.27264165G>A
-
-
-
-
2
-
-
Grabowski, 2001
;
Greenberg, 2003
Likely pathogenic
Pathogenic
N/A
APP_000028
-
-
-
-
-
-
-
./.
17
c.2113C>G
r.(?)
p.(Leu705Val)
Unknown
g.27264132C>G
-
-
-
-
-
-
Couldn't find paper online
Obici, 2005
Uncertain significance
Pathogenic
N/A
APP_000005
-
-
-
-
-
-
-
./.
17
c.2137G>A
r.(?)
p.(Ala713Thr)
Unknown
g.27264108G>A
-
-
-
-
5
-
-
Giaccone, 2002;
Rossi, 2004
;
Armstrong, 2004
;
Bernardi, 2009
Pathogenic
Pathogenic
N/A
APP_000006
-
-
-
-
-
-
-
./.
17
c.2140A>G
r.(?)
p.(Thr714Ala)
Unknown
g.27264105A>G
-
-
-
-
3
-
-
Pasalar, 2002
;
Zekanowski, 2003
;
Lindquist, 2008
;
Lindquist, 2009
Pathogenic
Pathogenic
N/A
APP_000013
-
-
-
-
-
-
-
./.
17
c.2141C>T
r.(?)
p.(Thr714Ile)
Unknown
G.27264104C>T
-
-
-
-
3
-
-
De Jonghe, 2000;
Kumar-Singh, 2000
;
De Jonghe, 2001
;
Edwards-Lee, 2005
;
Raux, 2005
Pathogenic
Pathogenic
N/A
APP_000014
-
-
-
-
-
-
-
./.
17
c.2143G>A
r.(?)
p.(Val715Met)
Unknown
g.27264102G>A
-
-
-
-
2
-
-
Ancolio, 1999
;
Campion, 1999
;
De Jonghe, 2001
;
Park, 2008
Likely pathogenic
Pathogenic
N/A
APP_000015
-
-
-
-
-
-
-
./.
17
c.2144T>C
r.(?)
p.(Val715Ala)
Unknown
g.27264101T>C
-
-
-
-
4
-
-
De Jonghe, 2001
; Cruts, 2002; Janssen, 2002;
Janssen, 2003
;
Cruts, 2003
;
Zekanowski, 2003
;
Wallon, 2002
Pathogenic
Pathogenic
N/A
APP_000016
-
-
-
-
-
-
-
./.
17
c.2146A>G
r.(?)
p.(Ile716Val)
Unknown
g.27264099A>G
-
-
-
-
1
-
-
Eckman, 1997
;
De Jonghe, 2001
Likely pathogenic
Pathogenic
N/A
APP_000017
-
-
-
-
-
-
-
./.
17
c.2146A>T
r.(?)
p.(Ile716Phe)
Unknown
g.27264099A>T
-
-
-
-
1
-
-
Clarimon, 2008;
Guardia-Laguarta, 2010
;
Guerreiro, 2010
Likely pathogenic
Pathogenic
N/A
APP_000018
-
-
-
-
-
-
-
./.
17
c.2147T>C
r.(?)
p.(Ile716Thr)
Unknown
g.27264098T>C
-
-
-
-
-
-
Couldn't find paper online
Terreni, 2002
Likely pathogenic
Pathogenic
N/A
APP_000007
-
-
-
-
-
-
-
./.
17
c.2148C>G
r.(?)
p.(Ile716Met)
Unknown
g.27264097C>G
1 AD patient
-
-
?
1
?
patient also had a novel CHMP2B p.A410T variant
Blauwendraat, 2016
Likely pathogenic
Pathogenic
Authors: pathogenic
APP_000008
-
-
-
-
-
-
-
./.
17
c.2149G>A
r.(?)
p.(Val717Ile)
Unknown
g.27264096G>A
-
-
-
-
38
-
-
Goate, 1991
;
Naruse, 1991
;
Hardy, 1991
;
Yoshioka, 1991
;
Fidani, 2002
;
Sorbi, 1993
;
Brooks, 1995
;
Matsumara, 1996
;
Campion, 1996
;
Campion, 1999
;
Finckh, 2000
;
De Jonghe, 2001
; Janssen, 2002;
Janssen, 2003
;
Tedde, 2003
;
Finckh, 2005
;
Raux, 2005
;
Brouwers, 2006
;
Wallon, 2002
;
Jiao, 2014
Pathogenic
Pathogenic
N/A
APP_000019
-
-
-
-
-
-
-
./.
17
c.2149G>C
r.(?)
p.(Val717Leu)
Unknown
g.27264096G>C
-
-
-
-
7
-
-
Murrell, 2000
;
De Jonghe, 2001
;
Finckh, 2005
;
Godbolt, 2006
; Ghetti, 2008;
Hooli, 2012
;
Sassi, 2014
Pathogenic
Pathogenic
N/A
APP_000020
-
-
-
-
-
-
-
./.
17
c.2149G>T
r.(?)
p.(Val717Leu)
Unknown
g.27264096G>T
-
-
-
-
3
-
-
Murrell, 1991
;
Finckh, 2005
Pathogenic
Pathogenic
N/A
APP_000021
-
-
-
-
-
-
-
./.
17
c.2150T>G
r.(?)
p.(Val717Gly)
Unknown
g.27264095T>G
-
-
-
-
2
-
-
Chartier-Harlin, 1991
; Knight, 2008;
Knight, 2009
Likely pathogenic
Pathogenic
N/A
APP_000022
-
-
-
-
-
-
-
./.
17
c.2168T>C
r.(?)
p.(Leu723Pro)
Unknown
g.27264077T>C
-
-
-
-
3
-
-
Kwok, 1998;
Kwok, 2000
;
Wallon, 2002
;
Dobricic, 2012
Pathogenic
Pathogenic
N/A
APP_000023
-
-
-
-
-
-
-
./.
17
c.2172G>C
r.(?)
p.(Lys724Asn)
Unknown
g.27264073G>C
1 AD patient
-
-
?
1
?
-
Theuns, 2006
Likely pathogenic
Pathogenic
Authors: likely pathogenic
APP_000009
-
-
-
-
-
-
-
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
Powered by
LOVD v.3.0
Build 21
LOVD software ©2004-2018
Leiden University Medical Center